NovaBridge Biosciences
NBP
Positions held
Your positionsNBP isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $158.92M | Enterprise value | -$27.47M | Trailing P/E | — | Forward P/E | -1.29 |
| PEG | — | Price / book | 0.79 | Beta | 1.60 | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | — | Gross margin | 0.0% | Operating margin | 0.0% |
| Profit margin | 0.0% | ROE | -59.1% | ROA | -35.0% | Debt / equity | 0.02 |
| Current ratio | 7.64 | Free cash flow | -$47.59M | Analyst recommendation | none | Mean target | $9.00 |
| 52w high | $6.79 | 52w low | $1.31 |
Quarterly
| 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M |
| Op margin | — | — | — | — |
| Net income | -$30.8M | -$6.8M | -$5.5M | -$3.1M |
| Gross margin | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating income | -$72.9M | -$9.0M | -$7.1M | -$5.3M |
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.6M | -$1.6M | — |
| Op margin | — | — | -7749.4% | 3422.2% | — |
| Net income | -$46.3M | -$22.2M | -$208M | -$371M | — |
| Gross margin | — | — | 617.1% | 2325.1% | — |
| Gross profit | — | — | $3.9M | -$36.1M | $6.5M |
| Operating income | -$94.3M | -$51.4M | -$49.0M | -$53.1M | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-09-08 · NovaBridge Appoints Martin Dewhurst to Board of Directors as an Independent Director
2026-08-27 · NovaBridge Biosciences to Participate in September Investor Conferences
2026-08-20 · NovaBridge Biosciences (NBP) (H1 2026) Earnings Call Highlights: Strong Cash Position and ...
2026-08-20 · NovaBridge Biosciences Q2 2026 Earnings Call Summary
2026-08-20 · NovaBridge Reports First Half 2026 Financial Results and Highlights Pipeline Momentum and Strategic Execution
2026-08-13 · NovaBridge to Report First Half 2026 Financial Results and Provide a Corporate Update on Thursday, August 20, 2026
2026-07-24 · NovaBridge Biosciences to Hold Annual General Meeting on September 8, 2026
Price (daily)
Full chart · RSI · MACD · patterns